Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
36.14
+0.51 (1.43%)
At close: Aug 14, 2026, 4:00 PM EDT
36.23
+0.09 (0.25%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Neurogene Employees
Neurogene had 131 employees as of December 31, 2025. The number of employees increased by 24 or 22.43% compared to the previous year.
Employees
131
Change (1Y)
24
Growth (1Y)
22.43%
Revenue / Employee
n/a
Profits / Employee
-$848,168
Market Cap
723.21M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 131 | 24 | 22.43% |
| Dec 31, 2024 | 107 | 16 | 17.58% |
| Dec 31, 2023 | 91 | 9 | 10.98% |
| Jun 30, 2023 | 82 | - | - |
| Dec 31, 2022 | 82 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| REGENXBIO | 371 |
| Allogene Therapeutics | 152 |
| Aura Biosciences | 113 |
| BridgeBio Oncology Therapeutics | 106 |
| CytomX Therapeutics | 69 |
| AgomAb Therapeutics NV | 62 |
| Candel Therapeutics | 55 |
NGNE News
- 4 days ago - Neurogene Slides: Corporate presentation - Filings
- 4 days ago - Neurogene reports Q2 EPS ($1.53), consensus ($1.38) - TheFly
- 4 days ago - Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates - Business Wire
- 4 days ago - Neurogene Earnings release: Q2 2026 - Filings
- 4 days ago - Neurogene Quarterly report: Q2 2026 - Filings
- 10 days ago - Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Neurogene prices 3.5M shares at $30.00 in public offering - TheFly
- 6 weeks ago - Neurogene Inc. Announces Pricing of $125 Million Public Offering - Business Wire